Skip to main content

Published locations for Atezolizumab plus bevacizumab offers a better prognosis than lenvatinib in unresectable HCC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Atezolizumab plus bevacizumab offers a better prognosis than lenvatinib in unresectable HCC

User login

  • Reset your password
  • /content/atezolizumab-plus-bevacizumab-offers-better-prognosis-lenvatinib-unresectable-hcc
  • /fedprac/article/255710/hepatocellular-carcinoma/atezolizumab-plus-bevacizumab-offers-better